Article Information
History
- December 24, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Jelissa Katharina Peter1,*,
- Fanny Wegner2,4,5,*,
- Severin Gsponer1,*,
- Fabrice Helfenstein3,
- Tim Roloff2,4,5,
- Rahel Tarnutzer1,
- Kerstin Grosheintz1,
- Moritz Back1,
- Carla Schaubhut1,
- Sabina Wagner1,
- Helena Seth-Smith2,4,5,
- Patrick Scotton6,
- Maurice Redondo7,
- Christiane Beckmann7,
- Tanja Stadler8,
- Andrea Salzmann7,
- Henriette Kurth7,
- Karoline Leuzinger9,10,
- Stefano Bassetti11,
- Roland Binggisser12,
- Martin Siegemund13,
- Maja Weisser14,
- Manuel Battegay14,
- Sarah Tschudin Sutter14,
- Aitana Lebrand15,
- Hans H. Hirsch7,10,14,
- Simon Fuchs1 and
- Adrian Egli2,4,+
- 1Health Services for the Canton of Basel-City, 4001 Basel, Switzerland
- 2Applied Microbiology Research, Department of Biomedicine, University of Basel, 4056 Basel, Switzerland
- 3Clinical Trial Unit, University Hospital Basel, 4031 Basel, Switzerland
- 4Division of Clinical Bacteriology and Mycology, University Hospital Basel, 4031 Basel, Switzerland
- 5SIB Swiss Institute of Bioinformatics, 4053-4056 Basel, Switzerland
- 6Corona Vaccination Centre for the Canton of Basel-City, 4058 Basel, Switzerland
- 7Viollier AG, Allschwil, Switzerland
- 8Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland
- 9Clinical Virology, University Hospital Basel, 4031 Basel, Switzerland
- 10Transplantation & Clinical Virology, Department of Biomedicine, University of Basel, 4056 Basel, Switzerland
- 11Internal Medicine, University Hospital Basel, 4031 Basel, Switzerland
- 12Emergency Medicine, University Hospital Basel, 4031 Basel, Switzerland
- 13Intensive Care Medicine, University Hospital Basel, 4031 Basel, Switzerland
- 14Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, 4031 Basel
- 15SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland
- ↵+Correspondence: Prof. Adrian Egli, MD PhD, Clinical Bacteriology and Mycology, Petersgraben 4, 4031 Basel, Switzerland, Email: adrian.egli{at}usb.ch
↵* authors equally contributed to the work
Posted December 24, 2021.
SARS-CoV-2 vaccine Alpha and Delta variant breakthrough infections are rare and mild, but happen relative early after vaccination
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
1
Blogs/Media
Author Videos